Skip to main content
Premium Trial:

Request an Annual Quote

Kirk Malloy

Edico Genome has appointed Kirk Malloy to its board of directors. He currently serves on the board of directors for Organovo. Prior to joining Edico Genome, Malloy served as a member of Illumina's executive team. He has also held commercial management positions at Biosite and Qiagen.

The Scan

Test of the China Initiative

According to Science, the upcoming trial of Harvard University chemist Charles Lieber will test the US China Initiative.

Collaborative Approach

A virologist who spotted the Omicron variant of SARS-CoV-2 tells the Associated Press that its detection was aided by scientific sharing.

Genes of a Guide Dog

Wired reports on a study aimed at uncovering genes involved in being a successful guide dog.

PLOS Papers on RNAs in Metastatic Prostate Cancer, Ebola Field Lab, Embryonic RNA Editing

In PLOS this week: circRNA-mediated ceRNA network points to prostate cancer biomarkers, Ebola testing at frontline field laboratory, and more.